Structure-Based Virtual Screening and De Novo Design of PIM1 Inhibitors with Anticancer Activity from Natural Products.
Hwangseo ParkJinwon JeonKewon KimSoyeon ChoiSungwoo HongPublished in: Pharmaceuticals (Basel, Switzerland) (2021)
these new PIM1 kinase inhibitors are anticipated to serve as a new starting point for the development of anticancer medicine.
Keyphrases